wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39290337-016CC52B-6649-41EE-BE3B-24FDE8790A37
Q39290337-016CC52B-6649-41EE-BE3B-24FDE8790A37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39290337-016CC52B-6649-41EE-BE3B-24FDE8790A37
Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.
P2860
Q39290337-016CC52B-6649-41EE-BE3B-24FDE8790A37
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39290337-016CC52B-6649-41EE-BE3B-24FDE8790A37
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1e27a08ba72819f562d07a14a4fe22cfacc75040
P2860
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease.